Thursday, 26 November 2015

SGX Stock News: iX Biopharma acccomplished Pilot Bioavailability Study

SGX Stocks Update: iX Biopharma has effectively finished a pilot bioavailability study for PheoniX™, an item right now being created for the treatment of male erectile brokenness.

PheoniX™ is one of three items right now a work in progress by the gathering. The item controls sildenafil by means of its exclusive sublingual medication conveyance innovation, Waferix™. The aftereffects of the pilot bioavailability study showed that the sublingual wafer detailing of PheoniX™ has a comparable rate and degree of medication ingestion as a Viagra® tablet. The gathering means to direct a vital bioequivalence study for promoting authorisation, got ready for the first quarter of 2016 as beforehand planned, to agree with the upscaling of business.

Except from this there are some more stocks are available who are ready to convert your Stock investment in to profit.

Today's Hot Stocks:
 Before Choose the stock for investment Get Live Stock Picks and its BUY/SELL positions with 

For more details and Free Stock , Forex & Comex Tips, Missed Call us at : +65 3158 6576, + 65-3158-2180 or connect with u son skype: mmfsolutionsg


No comments:

Post a Comment

Note: only a member of this blog may post a comment.